Drug intelligence / Profile preview

oxomemazine + guaifenesin

Development stage
Unknown
Lead developer
Combiphar
Modality
Small Molecules
Administration
Oral
01

Overview

Comtusi is a fixed-dose combination medication developed by Combiphar, primarily used to relieve coughs associated with allergic reactions and coughs with phlegm (productive coughs). It contains two active ingredients: oxomemazine, a first-generation phenothiazine antihistamine, and guaifenesin, an expectorant. Oxomemazine acts as an antagonist at histamine H1 receptors to alleviate allergy-induced cough and irritation, while also exhibiting mild anticholinergic and sedative properties. Guaifenesin works by increasing the volume and reducing the viscosity of respiratory tract secretions, facilitating the clearance of mucus from the airways. Comtusi is available in various formulations, including syrup (with a strawberry-flavored option for children) and a higher-strength capsule formulation (Comtusi Forte).

Brand names
ComtusiComtusi ForteComtusi SirupComtusi Sirup Rasa Strawberry
Other names
guaifenesin + oxomemazineoxomemazine + guaifenesinoxomemazine and guaifenesin
02

Targets

HRH1 (Histamine H1 Receptor)M1 (Muscarinic acetylcholine receptor M1)CHRM2 (M2)NMDAR (Glutamate receptor ionotropic, NMDA)

Beyond the preview

Go deeper on oxomemazine + guaifenesin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on oxomemazine + guaifenesin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call